FindTrial
Sign In

Effect of intravenous Zinc, Copper, Selenium, Maganese & Chromium in ICU patients.

Effects of Parenterally Administered Trace Elements â?? Zinc, Copper, Selenium, Chromium and Manganese in Critically Ill Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043949
Enrollment
96
Registered
2022-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R99- Ill-defined and unknown cause of mortality

Interventions

Intervention1: Trace elements: injection Multitrace 5 containing zinc,chromium,manganese,copper and selenium Control Intervention1: test group: Test group: shall receive injection multitrace-5 concent

Sponsors

Dr Mohd Mustahsin
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Critically ill patients admitted in Intensive Care Unit of Eraâ??s Lucknow Medical College And Hospital

Exclusion criteria

Exclusion criteria: Refusal for enrollment under study. Patients who are moribund. Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
28-day mortalityTimepoint: 28-day mortality—

Secondary

MeasureTime frame
To evaluate and assess: the length of stay in ICU length of stay in hospital Number of days on Mechanical Ventilation Number of days on vasopressorsTimepoint: 28-day mortality and 90 day follow up—

Countries

India

Contacts

Public Contactmustahsin malik

ERA LUCKNOW MEDICAL COLLEGE

mustahsin.malik@gmail.com9871559131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026